# reload+after+2024-01-21 07:47:32.512437
address1§101 Glen Lennox Drive
address2§Suite 300
city§Chapel Hill
state§NC
zip§27517
country§United States
phone§919 855 2100
website§https://www.tenaxthera.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension. It develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.
fullTimeEmployees§7
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Christopher T. Giordano', 'age': 48, 'title': 'CEO, President & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 563036, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stuart  Rich M.D.', 'age': 73, 'title': 'Chief Medical Officer & Director', 'yearBorn': 1950, 'fiscalYear': 2022, 'totalPay': 415996, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Doug  Randall', 'title': 'Executive Vice President of Commercial & Business Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Douglas  Hay', 'title': 'Senior Vice President of Regulatory Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§2.395
currency§USD
dateShortInterest§1702598400
forwardEps§-27.6
exchange§NCM
quoteType§EQUITY
shortName§Tenax Therapeutics, Inc.
longName§Tenax Therapeutics, Inc.
firstTradeDateEpochUtc§765466200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b61a8915-17b8-32f2-8c44-5f1ed46bfd83
gmtOffSetMilliseconds§-18000000
targetHighPrice§480.0
targetLowPrice§400.0
targetMeanPrice§440.0
targetMedianPrice§440.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§18.5
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
